Japanese genetic testing company Genesis Healthcare Co. said Feb. 27 that online retailer Rakuten Inc. and Omron Healthcare Co. Ltd. invested in Genesis to bring its valuation to ¥42 billion.
The details of the investment were not disclosed. Genesis said that this was Rakuten's second investment in Genesis. The retailer bought about ¥1.4 billion worth of Genesis shares in August 2017.
As of Feb. 26, US$1 was equivalent to ¥106.92.